Evidence map›Paper›PMID 33246469›Full record

ArticleBMC health services research2020

Potentially inappropriate testing for vitamin D deficiency: a cross-sectional study in Switzerland.

Stefan Essig, Christoph Merlo, Oliver Reich, Maria Trottmann

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Too much vitamin D? a drug safety review.Reviews in endocrine & metabolic disorders · 2026
    Review
  6. Article
  7. The impact of Choosing WiselyBMC health services research · 2025
    Article
  8. Knowledge about Vitamin D among General Population in Baghdad City.Rwanda journal of medicine and health sciences · 2024
    Article
  9. Non-indicated vitamin BBMJ open · 2024
    Article
  10. Observational
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Stefan EssigInstitute of Primary and Community Care, Schwanenplatz 7, 6004, Luzern, Switzerland. stefan.essig@iham-cc.ch.ORCID http://orcid.org/0000-0003-3228-7010
Christoph MerloInstitute of Primary and Community Care, Schwanenplatz 7, 6004, Luzern, Switzerland.
Oliver Reichsanté24, Palmstrasse 26b, 8401, Winterthur, Switzerland.
Maria TrottmannSWICA Health Services Research, Römerstrasse 38, 8401, Winterthur, Switzerland.
Community Care · USKantonsspital Winterthur · CHUniversity of Teacher Education Lucerne · CH

Funding

Swiss Medical Board (www.swissmedicalboard.ch) Unrestricted grant
6 · The paper itself

Abstract

backgroundThere is consensus that vitamin D supplementation is often indicated but population-based screening by laboratory testing for vitamin D deficiency is inadequate. Testing should be restricted to people at high risk of severe deficiency. This study describes the current lab testing for vitamin D deficiency in the adult population of Switzerland.

methodsWe assessed Swiss health insurance data (SWICA) for incidence of lab testing for vitamin D levels, comparing the years 2015 and 2018. Claims were analyzed for associations between lab testing and age, sex, medical indications, insurance status and geographic location in multivariable regression analyses. We also estimated the costs of vitamin D testing.

resultsData from 200,043 and 200,046 persons for 2015 and 2018, respectively, were analyzed. Vitamin D level was tested in 14% of the sample population in 2015 and 20% in 2018. Testing increased by 69% for individuals aged 26-30. Testing was associated with being middle-aged to young senior citizens, female, medical indications (pregnancy, renal disease, osteoporosis, hyperparathyroidism, HIV, glucocorticoid intake), more chronic conditions, having a mandatory insurance with a low deductible, additional insurance coverage, and living in urban areas. We estimate that the total laboratory cost to mandatory insurance was about 90 million Swiss francs in 2018.

conclusionsDespite recommendations for routine vitamin D supplementation, vitamin D testing of low risk individuals is common and increasing in Switzerland.

Indexed as

Blood Chemical AnalysisVitamin DAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedPregnancyPrevalenceSwitzerlandVitamin D DeficiencyVitamin DDiagnosisEvidence-based MedicineMedical overuseStandardsUnderuseVitamin DVitamin D deficiency

Identifiers

PMID33246469
PMCPMC7694269
OpenAlexW3109442580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.